USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 11,835 shares of the firm’s stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $66.07, for a total value of $781,938.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of USANA Health Sciences, Inc. (USNA) opened at $66.00 on Friday. The company has a market capitalization of $1,582.31, a price-to-earnings ratio of 17.45 and a beta of 1.07. USANA Health Sciences, Inc. has a 12 month low of $52.55 and a 12 month high of $71.00.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.91 by $0.11. The business had revenue of $261.77 million for the quarter, compared to the consensus estimate of $259.52 million. USANA Health Sciences had a return on equity of 25.56% and a net margin of 9.08%. The firm’s revenue was up 3.0% compared to the same quarter last year. During the same quarter last year, the business posted $2.40 EPS. equities research analysts predict that USANA Health Sciences, Inc. will post 3.7 earnings per share for the current year.

USANA Health Sciences announced that its Board of Directors has approved a stock buyback program on Tuesday, July 25th that allows the company to buyback $64.60 million in outstanding shares. This buyback authorization allows the company to buy up to 46% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.

WARNING: “Myron W. Wentz Sells 11,835 Shares of USANA Health Sciences, Inc. (USNA) Stock” was posted by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/11/18/myron-w-wentz-sells-11835-shares-of-usana-health-sciences-inc-usna-stock.html.

A number of institutional investors have recently modified their holdings of USNA. Northern Trust Corp raised its stake in shares of USANA Health Sciences by 10.5% in the 2nd quarter. Northern Trust Corp now owns 177,630 shares of the company’s stock valued at $11,386,000 after purchasing an additional 16,948 shares during the period. American International Group Inc. raised its stake in shares of USANA Health Sciences by 7.1% in the 1st quarter. American International Group Inc. now owns 6,392 shares of the company’s stock valued at $368,000 after purchasing an additional 422 shares during the period. Trust Co. of Vermont raised its stake in shares of USANA Health Sciences by 482.7% in the 3rd quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock valued at $272,000 after purchasing an additional 3,900 shares during the period. Schroder Investment Management Group raised its stake in shares of USANA Health Sciences by 9.0% in the 2nd quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock valued at $36,734,000 after purchasing an additional 47,448 shares during the period. Finally, FMR LLC raised its stake in shares of USANA Health Sciences by 3.9% in the 2nd quarter. FMR LLC now owns 1,598,143 shares of the company’s stock valued at $102,441,000 after purchasing an additional 60,033 shares during the period. 44.54% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have recently issued reports on USNA. BidaskClub lowered USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research report on Monday, July 31st. Pivotal Research raised their price target on USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, October 25th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.